FDA-Cleared Clairity Breast AI Predicts 5-Year Cancer Risk From a Normal Mammogram
EricTopol · x · 2026-10-05
The New York Times front-pages the national rollout of Clairity Breast, an FDA-cleared AI tool that predicts a woman's five-year breast cancer risk from a single routine mammogram, outputting a 0-100% probability score — a different purpose from AI that detects existing cancers.
Key points:
- Digital health company Everlywell is making the tool available nationwide starting Thursday; previously limited to select sites in Massachusetts and Colorado.
- It costs $249 and is not covered by insurance.
- Eric Topol argues the test should be free and part of every mammogram readout.
- The piece follows a 65-year-old patient who took preventive steps after the AI flagged elevated risk.
More from Apps
- Threads' hold-to-cut-out gesture is powered by Meta's SAM segmentation model — nikhilaravi · 2026-10-06
- Reporter says Apple's Muse read his messages with integration off; Apple reexamines permissions — StewartalsopIII · 2026-10-06
- 12 practical tips for writing with AI using a multi-tab Google Doc workflow — every · 2026-10-06
- User: my favorite new Siri feature is 'Turn Off Siri' — shaunralston · 2026-10-05
- Google upgrades NotebookLM with deeper Gemini Notebook integration, plus 8 research prompts — Aiden_Tech_Ai · 2026-10-05
- Claude Code can now read full docs via NotebookLM MCP without spending a token — Aiden_Tech_Ai · 2026-10-05